Country Profile

Vietnam

Vietnam is a major destination for Indian pharmaceutical exports — $291M in FY 2025–26. Medicines accounts for 55% of shipments, with vaccines contributing $14.1M. The compound annual growth rate since FY2015 stands at 3.0%.

🇻🇳 #17 Destination · $291M · 1.4× growth since FY2015
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$291M
Exports FY2025–26 DGCIS
1.4×
Growth FY2015→2026
0.9%
Share of India Total
#17
Rank Among 178 Markets
3.0%
CAGR FY2015→2026
Vietnam is a major destination for Indian pharmaceutical exports — $291M in FY 2025–26. Medicines accounts for 55% of shipments, with vaccines contributing $14.1M. The compound annual growth rate since FY2015 stands at 3.0%.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicines $159M (54.7%) Medicine Ingredients $86.3M (29.7%) Traditional & Herbal $24.6M (8.5%) Vaccines $14.1M (4.8%) Surgical & Hospital Supplies $6.64M (2.3%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Vietnam in the RBI overseas direct investment dataset (2011–2026).